Evidence map›Paper›PMID 41540733›Full record

ArticleCPT: pharmacometrics & systems pharmacology2026

Integrating Population Approaches With Physiologically Based Pharmacokinetic Models: A Novel Framework for Parameter Estimation.

Donato Teutonico, David Marchionni, Marc Lavielle, Laurent Nguyen

Abstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling.CPT: pharmacometrics & systems pharmacology · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Donato TeutonicoPharmacometrics, Translational Medicine Unit, Sanofi, Vitry-sur-Seine, France.ORCID https://orcid.org/0000-0003-4931-410X
David MarchionniPharmacometrics, Translational Medicine Unit, Sanofi, Montpellier, France.
Marc LavielleInria, Saclay, France.ORCID https://orcid.org/0000-0003-2680-6339
Laurent NguyenPharmacometrics, Translational Medicine Unit, Sanofi, Vitry-sur-Seine, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Physiologically Based Pharmacokinetic (PBPK) modeling is a powerful tool in drug development that integrates drug-specific information with physiological parameters to predict drug concentrations. However, parameter estimation in PBPK models presents significant challenges due to the large number of parameters involved and limited observed data. This tutorial introduces a novel approach coupling whole-body PBPK (WB-PBPK) models with population estimation methods (popWB-PBPK) to leverage individual data and estimate inter-individual variability on physiologically relevant parameters. The framework employs an optimized Stochastic Approximation Expectation-Maximization (SAEM) algorithm, reducing the estimation runtime through an adaptive parameter grid optimization and linear interpolation techniques. Using theophylline as a case study, we illustrate how this approach can accurately estimate drug-specific parameters (CYP1A2 clearance and lipophilicity) while incorporating covariate effects (smoking status). The optimized algorithm significantly reduces computational time compared to the standard SAEM algorithm. Our implementation in the saemixPBPK R package provides an accessible framework for parameter estimation in PBPK models, enabling more robust predictions of pharmacokinetic behavior leveraging individual data. This approach represents an important advancement in mechanistic modeling, allowing simultaneous estimation of population parameters, variability, and uncertainty while maintaining the physiological relevance of PBPK models.

Indexed as

Models, BiologicalPharmacokineticsTheophyllineAlgorithmsComputer SimulationCytochrome P-450 CYP1A2Drug DevelopmentHumansCYP1A2 protein, humanCytochrome P-450 CYP1A2Theophyllineindividual variabilityPBPKphysiologically based pharmacokineticspopPBPKpopWB‐PBPKSAEM

Identifiers

PMID41540733
PMCPMC12823310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.